ProLUNG3D – a lung-protective strategy

NIKKISO Prolung 1920X1080px Rgbwhite Background

Mini-invasive extracorporeal CO2 removal system

Enable Protective Ventilation – Achieve > 90 mL/min CO2 removal and a reduction of 50% MV during ultraprotective ventilation

Prevent Intubation – For patients presenting with ae-COPD and failing NIV

Bridge to transplant – Reduce hypercapnia and acidosis, reducing the risk of transplantation failure

Facilitate extubation – To reduce the risk of ventilator associated complications and work of breathing

ProLUNG® Clinical Applications Guide

Patient selection is a critical step in extracorporeal CO₂ removal therapy. This practical guide provides clear, evidence-referenced decision pathways for the use of LF-ECCO₂R in ARDS, acute exacerbation of COPD, and other indications – helping ICU clinicians determine which patients are most likely to benefit. Download it to support your team's patient selection process and lung-protective strategy.

Whether you are establishing an ECCO₂R programme or refining your patient selection criteria, this guide provides a concise, evidence-referenced framework you can apply in practice. It is designed not to replace local protocols, but to complement them – giving your team a shared clinical language and a structured approach to one of critical care's most complex decisions.

To check registration and availability in your country or for further information, please contact your local Aquarius representative or email Sales@norrdia.com.